专利检索 ap:("Allergan, Inc.") AND inv:"Ursula Staubli" 第 1 页

1.

发明申请
BRIMONIDINE FOR TREATING VISUAL DISORDERS MEDIATED BY CENTRAL VISUAL PROJECTIONS FROM THE EYE 审中-公开
标题翻译：用于治疗眼睛中央视觉投射介导的视觉障碍的甘露辛

公开(公告)号：US20130197002A1

公开(公告)日：2013-08-01

申请号：US13752871

申请日：2013-01-29

申请人： Allergan, Inc.

发明人： Ursula Staubli , Alan C. Foster , Daniel W. Gil , John E. Donello

IPC分类号： A61K31/498

CPC分类号： A61K31/498

摘要： The present invention relates to a method for treating visual disorders mediated by lateral geniculate nucleus, superior colliculus and the visual cortex by administering to a patient in need of such treatment, compounds acting at the alpha 2 adrenergic receptor.

摘要翻译： 本发明涉及通过向需要这种治疗的患者施用在α2肾上腺素能受体上起作用的化合物来治疗外侧膝状核，上丘和视皮质介导的视觉障碍的方法。

2.

发明申请
D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS 审中-公开

公开(公告)号：US20170172957A1

公开(公告)日：2017-06-22

申请号：US15223985

申请日：2016-07-29

申请人： Allergan, Inc.

发明人： Alan C. Foster , Yong-Xin Li , Ursula Staubli , Veena Viswanath , Lauren Luhrs

IPC分类号： A61K31/197 , A61K31/401

CPC分类号： A61K31/197 , A61K31/196 , A61K31/198 , A61K31/216 , A61K31/401 , A61K31/405 , A61K45/06 , A61K2300/00

摘要： The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of central nervous system disorders.